ELL
ELL (elongation factor for RNA polymerase II, also known as Men, ELL1, PPP1R68 and C19orf17) is a nuclear transcription elongation factor. It acts within the super elongation complex and the little elongation complex to support RNA polymerase II transcription and snRNA gene expression. Browse Assay Genie's current range of ELL research reagents below, or read on for the biology behind the target.
ELL is an elongation factor component of the super elongation complex (SEC), which increases the catalytic rate of RNA polymerase II transcription by suppressing transient pausing by the polymerase at multiple sites along the DNA. It is also an elongation factor component of the little elongation complex (LEC), which regulates small nuclear RNA (snRNA) gene transcription by RNA polymerase II and III. Within this role, ELL is specifically required for stimulating the elongation step of RNA polymerase II- and III-dependent snRNA gene transcription.
ELL also acts early, before it assembles into the SEC. At this stage it stabilises RNA polymerase II recruitment and initiation, and entry into the pause site, and it helps stabilise the pre-initiation complex and early elongation. The ELL protein localises to the nucleus, including nuclear speckles and Cajal bodies. NCBI Gene annotation describes it as enabling phosphatase binding, involved in positive regulation of DNA-templated transcription and snRNA transcription, located in euchromatin and nuclear ribonucleoprotein granules, and part of the transcription elongation factor complex. It belongs to the ELL/occludin family.
The ELL gene is also listed by HGNC as PPP1R68, within the protein phosphatase 1 regulatory subunits group, and in the super elongation complex gene group. Earlier names include chromosome 19 open reading frame 17 (C19orf17) and elongation factor RNA polymerase II, and the gene is also written Men or ELL1. A mouse ortholog, Ell, is annotated. Researchers studying ELL commonly work on transcriptional control, snRNA gene expression and the composition of elongation complexes.
ELL suppresses transient pausing by RNA polymerase II at multiple sites, making it a key factor for studying how elongation rates are regulated.
As a component of the little elongation complex, ELL is required for RNA polymerase II- and III-dependent snRNA gene transcription.
ELL is an elongation factor component of the SEC and also acts before assembly into it, stabilising polymerase recruitment and initiation.
ELL is found in nuclear speckles and Cajal bodies, supporting work on how transcription factors are organised within the nucleus.
ELL is an elongation factor in the super elongation complex, where it helps raise the catalytic rate of RNA polymerase II by suppressing transient pausing. In the little elongation complex it supports snRNA gene transcription. It also stabilises the pre-initiation complex and early elongation.
ELL is also called Men, ELL1 and PPP1R68, and was previously known as C19orf17 (chromosome 19 open reading frame 17). The UniProt protein name is RNA polymerase II elongation factor ELL, and HGNC lists the full gene name as elongation factor for RNA polymerase II.
A mouse ortholog, Ell, is annotated for the human gene. ELL belongs to the ELL/occludin family. For work in other species, check the datasheet of any product for its validated reactivity.
Other super elongation complex and little elongation complex components, and related transcription elongation factors.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P55199; product specifications from Assay Genie datasheets.